Seeking Alpha

Boston Scientific to acquire Bayer unit for $415M

  • Boston Scientific (BSX) has agreed to acquire Bayer's (BAYRY) Interventional device business for $415M.
  • The deal that will strengthen Boston's portfolio of products for treating peripheral vascular disease, with the company to receive systems used in cardiology, radiology and peripheral vascular procedures.
  • The unit generated $120M in sales last year. (PR)
Comments (1)
  • Roxieanne
    , contributor
    Comments (755) | Send Message
     
    I missed the article about the Bayer unit acquisition. Is this the Bayer that makes aspirin.
    1 Sep 2014, 03:15 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs